| Line Item | 2025-06-27 | Y/Y |
|---|---|---|
| Revenue | $7.36B | +10.4% |
| Cost of Revenue | $5.14B | -8.0% |
| Gross Profit | $2.21B | +106.3% |
| R&D Expense | $1.13B | +6.7% |
| SG&A Expense | $573.0M | +25.9% |
| Operating Income | -$1.38B | -194.2% |
| Pre-tax Income | -$1.48B | -194.0% |
| Income Tax | $162.0M | -4.1% |
| Net Income | -$1.64B |
| Line Item | 2025-06-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.48B | +351.5% |
| Accounts Receivable | $1.07B | +14.2% |
| Inventory | $2.08B | +6.3% |
| Current Assets | $5.09B | +43.3% |
| Total Assets | $12.98B | -3.9% |
| Current Liabilities | $1.43B | -32.8% |
| Long-term Debt | $1.85B | — |
| Line Item | 2025-06-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $84.0M | +127.2% |
| Capital Expenditures | $204.0M | +22.9% |
| Investing Cash Flow | $556.0M | +164.8% |
| Financing Cash Flow | $518.0M | +280.9% |
| Free Cash Flow | -$120.0M | +74.7% |
| -144.2% |
| EPS (Basic) | -$11.32 | -144.5% |
| EPS (Diluted) | -$11.32 | -144.5% |
| Total Liabilities |
| $3.77B |
| +55.5% |
| Stockholders' Equity | $9.22B | -16.8% |